Sign in
Back
Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting
Journal article   Open access  Peer reviewed

Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting

Vakaramoko Diaby, Ching-Yu Wang, Hussain Alqhtani, Sascha van Boemmel-Wegmann, Askal Ayalew Ali, Rajesh Balkrishnan, Yu Ko, Sofia Palacio and Gilberto de Lima Lopes
Data in brief, Vol.29, pp.105194-105194
01/04/2020
DOI: https://doi.org/10.1016/j.dib.2020.105194
PMCID: PMC7011026
PMID: 32071975

Abstract

Cost-effectiveness analysis Markov model Metastatic breast cancer Treatment sequence
The present data article aims to describe the input parameters for a Markov model assessing the cost-effectiveness of four treatment sequences for patients with HER-2 positive metastatic breast cancer. The model input parameters include costs for physician visits, drugs, adverse event management, computed tomography (CT) scan, laboratory tests, echocardiogram, utilities, disutilities as well as the shape and scale parameters of a log-logistic distribution used for the transition probabilities.
url
https://doi.org/10.1016/j.dib.2020.105194View
Published (Version of record) Open

Metrics

1 Record Views

Details